A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults

Clinical trial NCT04505098 · TERMINATED

Trial details

NCT number: NCT04505098
Sponsor: Kaiser Permanente
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Covid19 Atherosclerosis Cardiovascular Diseases Upper Respiratory Tract Infections

Start date: 2020-08-07
Primary completion: 2022-12-15
Enrollment: 39600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.